Akavar

Akavar 20/50 is an over-the-counter weight-loss supplement manufactured by Dynakor Pharmacal. Akavar was recently released for sale in the United States in July 2007 and is sold in retail stores such as Wal-Mart and GNC, and also online directly from its manufacturer.

Although many marketing claims promise rapid, guaranteed results "or your money back," information regarding how Akavar works and what makes it effective is not readily available. Akavar purportedly assists in weight loss through caloric intake restriction.

Akavar is marketed as a "European Breakthrough" in part because the blend of ingredients are based on government patents in Europe.

"Eat All You Want and Still Lose Weight" is the tagline for the product based on the manufacturer's reported "studies" that due to the caloric restrictor capabilities of Akavar you will still lose weight and be able to eat all you want.

The "scientific research" done on Akavar 20/50 consists of 24 people taking Akavar over a period of time without changing their diet or increasing their exercise. Nearly 100% of the participants, 23 of the 24 people lost weight using Akavar. Dynakor Pharmacal, Akavar's manufacturer, now markets these results and claims that you can "eat all you want and still lose weight."

:
Yerba Mate, Caffeine, Guarana, Damiana, Green Tea, Ginger, Kola, Schisandra, Scutellaria, Ginseng, Cocoa, Jujube, Thea Sinensis. These are mostly herbal and are common in a variety of other weight loss supplements.

Akavar competition such as Hoodia & Ephedrine based products have tried to dispel any Akavar claims and have even set up many anti-akavar websites.

Akavar's TV commercials state that they couldn't make claims about the effectiveness of their product on TV if they weren't true. This statement is not supported by historical fact, many TV ads have contained mistruths or misleading statements, and the advertisers are subsequently fined.

Akavar's print advertisements state, "we couldn't say it in print if it wasn't true!" Under the Freedom of the Press clause in the First Amendment of the United States Constitution there is no restriction on what you can "say in print" and Akavar certainly is not restricted to printing only the truth. The only restriction is that they cannot make claims of pharmaceutical efficacy without the approval of the Food and Drug Administration, and they say "These statements have not been evaluated by the Food and Drug Administration."

Main Menu

See Also

Main Menu